UniProt ID | TRUA_HUMAN | |
---|---|---|
UniProt AC | Q9Y606 | |
Protein Name | tRNA pseudouridine synthase A | |
Gene Name | PUS1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 427 | |
Subcellular Localization |
Isoform 1: Mitochondrion . Isoform 2: Nucleus . |
|
Protein Description | Converts specific uridines to PSI in a number of tRNA substrates. Acts on positions 27/28 in the anticodon stem and also positions 34 and 36 in the anticodon of an intron containing tRNA. Involved in regulation of nuclear receptor activity through pseudouridylation of SRA1 RNA.. | |
Protein Sequence | MGLQLRALLGAFGRWTLRLGPRPSCSPRMAGNAEPPPAGAACPQDRRSCSGRAGGDRVWEDGEHPAKKLKSGGDEERREKPPKRKIVLLMAYSGKGYHGMQRNVGSSQFKTIEDDLVSALVRSGCIPENHGEDMRKMSFQRCARTDKGVSAAGQVVSLKVWLIDDILEKINSHLPSHIRILGLKRVTGGFNSKNRCDARTYCYLLPTFAFAHKDRDVQDETYRLSAETLQQVNRLLACYKGTHNFHNFTSQKGPQDPSACRYILEMYCEEPFVREGLEFAVIRVKGQSFMMHQIRKMVGLVVAIVKGYAPESVLERSWGTEKVDVPKAPGLGLVLERVHFEKYNQRFGNDGLHEPLDWAQEEGKVAAFKEEHIYPTIIGTERDERSMAQWLSTLPIHNFSATALTAGGTGAKVPSPLEGSEGDGDTD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
26 | Phosphorylation | LGPRPSCSPRMAGNA CCCCCCCCCCCCCCC | 21.63 | 28555341 | |
67 | Acetylation | EDGEHPAKKLKSGGD CCCCCCHHHCCCCCC | 64.19 | 25953088 | |
110 | Ubiquitination | NVGSSQFKTIEDDLV CCCCHHCCCHHHHHH | 40.74 | - | |
138 | Phosphorylation | GEDMRKMSFQRCART CHHHHHHHHHHHHCC | 22.66 | 24719451 | |
145 | Phosphorylation | SFQRCARTDKGVSAA HHHHHHCCCCCCCCC | 24.44 | 29759185 | |
147 | Acetylation | QRCARTDKGVSAAGQ HHHHCCCCCCCCCCC | 61.67 | 25953088 | |
147 | Malonylation | QRCARTDKGVSAAGQ HHHHCCCCCCCCCCC | 61.67 | 26320211 | |
150 | Phosphorylation | ARTDKGVSAAGQVVS HCCCCCCCCCCCEEE | 22.52 | - | |
176 | Phosphorylation | KINSHLPSHIRILGL HHHHCCCCCEEEECC | 37.60 | - | |
187 | Phosphorylation | ILGLKRVTGGFNSKN EECCCCCCCCCCCCC | 35.30 | 25599653 | |
201 | Phosphorylation | NRCDARTYCYLLPTF CCCCHHHHHHHHHHH | 3.58 | 22210691 | |
207 | Phosphorylation | TYCYLLPTFAFAHKD HHHHHHHHHHHHCCC | 27.80 | 22210691 | |
221 | Phosphorylation | DRDVQDETYRLSAET CCCCCCCHHCCCHHH | 23.41 | 20068231 | |
222 | Phosphorylation | RDVQDETYRLSAETL CCCCCCHHCCCHHHH | 13.91 | 22210691 | |
239 | Phosphorylation | VNRLLACYKGTHNFH HHHHHHHHCCCCCCC | 13.57 | 22817900 | |
249 | Phosphorylation | THNFHNFTSQKGPQD CCCCCCCCCCCCCCC | 35.25 | 28857561 | |
250 | Phosphorylation | HNFHNFTSQKGPQDP CCCCCCCCCCCCCCH | 26.25 | 20873877 | |
342 | Acetylation | LERVHFEKYNQRFGN EEEEEHHHHHHHCCC | 48.86 | 26822725 | |
364 | Ubiquitination | DWAQEEGKVAAFKEE HHHHHHCCEEEEEHH | 31.79 | - | |
369 | Ubiquitination | EGKVAAFKEEHIYPT HCCEEEEEHHHCCCE | 58.42 | - | |
369 | 2-Hydroxyisobutyrylation | EGKVAAFKEEHIYPT HCCEEEEEHHHCCCE | 58.42 | - | |
380 | Phosphorylation | IYPTIIGTERDERSM CCCEECCCCCCHHHH | 19.89 | 24719451 | |
392 | Phosphorylation | RSMAQWLSTLPIHNF HHHHHHHHCCCCCCC | 25.57 | 19664995 | |
415 | Phosphorylation | GTGAKVPSPLEGSEG CCCCCCCCCCCCCCC | 45.14 | 30266825 | |
420 | Phosphorylation | VPSPLEGSEGDGDTD CCCCCCCCCCCCCCC | 29.09 | 23927012 | |
426 | Phosphorylation | GSEGDGDTD------ CCCCCCCCC------ | 49.49 | 25159151 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TRUA_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TRUA_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TRUA_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ARP3_HUMAN | ACTR3 | physical | 22863883 | |
GDE_HUMAN | AGL | physical | 22863883 | |
ARPC2_HUMAN | ARPC2 | physical | 22863883 | |
BCAT1_HUMAN | BCAT1 | physical | 22863883 | |
SYFA_HUMAN | FARSA | physical | 22863883 | |
IDE_HUMAN | IDE | physical | 22863883 | |
NCBP1_HUMAN | NCBP1 | physical | 22863883 | |
NRDC_HUMAN | NRD1 | physical | 22863883 | |
NSUN2_HUMAN | NSUN2 | physical | 22863883 | |
PFD1_HUMAN | PFDN1 | physical | 22863883 | |
PFD5_HUMAN | PFDN5 | physical | 22863883 | |
RFA1_HUMAN | RPA1 | physical | 22863883 | |
SP100_HUMAN | SP100 | physical | 22863883 | |
VPS29_HUMAN | VPS29 | physical | 22863883 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
600462 | Myopathy with lactic acidosis and sideroblastic anemia 1 (MLASA1) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-415; SER-420 ANDTHR-426, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-420 AND THR-426, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-420 AND THR-426, ANDMASS SPECTROMETRY. | |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-426, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-426, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-239, AND MASSSPECTROMETRY. |